Morgan Stanley Tandem Diabetes Care Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Morgan Stanley holds 992,711 shares of TNDM stock, worth $35.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

992,711

Previous 1,019,411 2.62%

Holding current value

$35.8 Million

Previous $41.1 Million 2.48%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$35.21 - $47.3 $940,107 - $1.26 Million	-26,700 Reduced 2.62%	992,711 $42.1 Million
Q2 2024 Oct 17, 2024	SELL	$30.43 - $53.43 $11.5 Million - $20.2 Million	-378,734 Reduced 27.09%	1,019,411 $41.1 Million
Q2 2024 Aug 14, 2024	SELL	$30.43 - $53.43 $11.5 Million - $20.2 Million	-378,734 Reduced 27.09%	1,019,411 $41.1 Million
Q1 2024 Oct 17, 2024	BUY	$22.09 - $35.41 $8.37 Million - $13.4 Million	378,734 Added 37.15%	1,398,145 $49.5 Million
Q1 2024 Aug 16, 2024	BUY	$22.09 - $35.41 $11.6 Million - $18.6 Million	525,980 Added 60.31%	1,398,145 $49.5 Million
Q1 2024 May 15, 2024	BUY	$22.09 - $35.41 $11.6 Million - $18.6 Million	525,980 Added 60.31%	1,398,145 $49.5 Million
Q4 2023 Aug 16, 2024	SELL	$14.28 - $31.03 $2.1 Million - $4.57 Million	-147,246 Reduced 14.44%	872,165 $25.8 Million
Q4 2023 Feb 13, 2024	BUY	$14.28 - $31.03 $1.39 Million - $3.03 Million	97,522 Added 12.59%	872,165 $25.8 Million
Q3 2023 Nov 15, 2023	BUY	$19.33 - $36.22 $7.18 Million - $13.5 Million	371,356 Added 92.08%	774,643 $16.1 Million
Q2 2023 Aug 14, 2023	SELL	$24.18 - $42.46 $12.8 Million - $22.4 Million	-528,485 Reduced 56.72%	403,287 $9.9 Million
Q1 2023 May 15, 2023	BUY	$35.86 - $46.5 $16.4 Million - $21.2 Million	456,222 Added 95.94%	931,772 $37.8 Million
Q4 2022 Feb 14, 2023	BUY	$35.49 - $56.15 $5.36 Million - $8.48 Million	150,957 Added 46.51%	475,550 $21.4 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $68.97 $9.05 Million - $14.3 Million	-206,870 Reduced 38.92%	324,593 $15.5 Million
Q2 2022 Oct 27, 2022	BUY	$53.22 - $123.09 $19.1 Million - $44.1 Million	358,364 Added 207.03%	531,463 $31.5 Million
Q2 2022 Aug 15, 2022	BUY	$53.22 - $123.09 $19.1 Million - $44.1 Million	358,364 Added 207.03%	531,463 $31.5 Million
Q1 2022 Oct 27, 2022	SELL	$101.89 - $150.09 $36.5 Million - $53.8 Million	-358,364 Reduced 67.43%	173,099 $20.1 Million
Q1 2022 May 13, 2022	SELL	$101.89 - $150.09 $30.9 Million - $45.5 Million	-303,197 Reduced 63.66%	173,099 $20.1 Million
Q4 2021 Feb 14, 2022	BUY	$118.18 - $153.21 $19.7 Million - $25.5 Million	166,438 Added 53.71%	476,296 $71.7 Million
Q3 2021 Nov 15, 2021	BUY	$93.51 - $129.4 $29 Million - $40.1 Million	309,858 New	309,858 $37 Million

Others Institutions Holding TNDM

# of Institutions

360

Shares Held

72.2M

Call Options Held

3.36M

Put Options Held

229K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.31B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account